Achieving safer Ramadan fasting by keeping flexible glycemic targets during the day and tighter targets during the night in insulin treated people with type 2 diabetes

Diabetes Res Clin Pract. 2020 Jul:165:108234. doi: 10.1016/j.diabres.2020.108234. Epub 2020 May 23.

Abstract

Aim: To observe the effect of keeping flexible glycemic targets during fasting and tighter targets during non-fasting hours in insulin-treated people with type 2 diabetes during Ramadan.

Methods: This prospective study was conducted at Baqai Institute of Diabetology and Endocrinology in 2014. People with T2DM on split mixed insulin therapy were recruited. The pre-Ramadan education given and insulin doses were adjusted before Ramadan. 24-hour telephonic helpline service was provided to achieve pre-determined glycemic targets and minimize complications.

Results: A total of 54 people with T2DM with a mean age of 54.65 ± 9.32 years were recruited. Mean glucose levels achieved were 183.50 ± 30.91 mg/dl and 179.20 ± 36.27 mg/dl during the day and night respectively. Mean HbA1c (p-value < 0.0001) and serum creatinine (p-value 0.0010) significantly improved at the end of Ramadan. 0.6% episodes of hypoglycemia including one major hypoglycemia while 30% of episodes of hyperglycemia were recorded. No hospitalization needed.

Conclusion: By keeping flexible glycemic targets during the day and tighter targets during the night, safe fasting was feasible with significant improvement in overall glycemic control without significant major complications.

Keywords: Flexible glycemic targets; Ramadan; Safe fasting; Tighter glycemic targets; Type 2 diabetes.

MeSH terms

  • Adult
  • Biphasic Insulins / therapeutic use
  • Blood Glucose / analysis
  • Blood Glucose Self-Monitoring
  • Creatinine / analysis
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Fasting / blood*
  • Female
  • Holidays
  • Humans
  • Hyperglycemia / blood
  • Hypoglycemia / blood
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use*
  • Islam*
  • Male
  • Middle Aged
  • Prospective Studies

Substances

  • Biphasic Insulins
  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Creatinine